FDA approves new treatment for advanced melanoma
On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.